Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GRICVE:IWGCVE:SVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRIGRI Bio$1.34+3.1%$1.50$1.10▼$59.33$2.87M-1.68289,263 shs64,301 shsIWG90624 (IWG.V)C$0.00C$0.27▼C$0.43N/AN/A297,155 shsN/ASVSSolarvest BioEnergyC$0.03C$0.02C$0.01▼C$0.14C$1.52M1.577,594 shs3,159 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRIGRI Bio0.00%-5.80%-13.33%-76.87%-97.42%SVSSolarvest BioEnergy0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGRIGRI Bio2.069 of 5 stars3.52.00.00.01.90.01.3IWG90624 (IWG.V)N/AN/AN/AN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGRIGRI Bio 3.00Buy$22.001,541.79% UpsideIWG90624 (IWG.V) 0.00N/AN/AN/ASVSSolarvest BioEnergy 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest GWI, IWG, GRI, and SVS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025GRIGRI BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/27/2025GRIGRI BioAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$40.00 ➝ $34.004/14/2025GRIGRI BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.00(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGRIGRI BioN/AN/AN/AN/A$5.22 per shareN/AIWG90624 (IWG.V)N/AN/AN/AN/AN/AN/ASVSSolarvest BioEnergyC$740.002,052.70C$0.00 per share55.00C($0.10) per share-0.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGRIGRI Bio-$13.04M-$11.56N/AN/AN/AN/A-289.05%-165.01%8/12/2025 (Estimated)IWG90624 (IWG.V)N/AN/A0.00N/AN/AN/AN/AN/AN/ASVSSolarvest BioEnergy-C$2.26M-C$0.04N/A∞N/AN/AN/A-143.12%N/ALatest GWI, IWG, GRI, and SVS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025GRIGRI Bio-$4.08-$5.80-$1.72-$5.80N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGRIGRI Bio$1.91142.54%N/AN/A N/AIWG90624 (IWG.V)N/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGRIGRI BioN/A3.103.10IWG90624 (IWG.V)N/AN/AN/ASVSSolarvest BioEnergyN/AN/A0.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGRIGRI Bio33.95%IWG90624 (IWG.V)N/ASVSSolarvest BioEnergyN/AInsider OwnershipCompanyInsider OwnershipGRIGRI Bio0.13%IWG90624 (IWG.V)N/ASVSSolarvest BioEnergy15.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGRIGRI Bio12.14 million8.92 millionNot OptionableIWG90624 (IWG.V)N/A39.36 millionN/ANot OptionableSVSSolarvest BioEnergyN/A60.76 millionN/ANot OptionableGWI, IWG, GRI, and SVS HeadlinesRecent News About These CompaniesSolarvest continues to make hay as the sun shinesJune 10, 2025 | thestar.com.myA Look At The Intrinsic Value Of Solarvest Holdings Berhad (KLSE:SLVEST)May 27, 2025 | finance.yahoo.comSolarvest order book to surpass RM2bil in FY26May 21, 2025 | thestar.com.mySolarvest optimistic orderbook to surpass RM2bil in FY26May 21, 2025 | thestar.com.myMIDA Facilitates RM142 Mln Energy Partnership Between Solarvest, HSS & Shizen At Osaka ExpoApril 17, 2025 | bernama.comWhile private companies own 23% of Solarvest Holdings Berhad (KLSE:SLVEST), individual investors are its largest shareholders with 32% ownershipApril 16, 2025 | finance.yahoo.comSolarvest order book hits record RM1.4bilMarch 27, 2025 | thestar.com.mySolarvest maintains sunny outlookMarch 27, 2025 | thestar.com.mySolarvest To Be Prime Beneficiary Of Large-scale Solar Contracts - HLIBMarch 27, 2025 | bernama.comSolarvest unit wins RM103mil EPCC contractMarch 27, 2025 | thestar.com.mySolarvest unit secures RM103.08mil EPCC contract for solar PV facility in Pulau PinangMarch 26, 2025 | thestar.com.myUpbeat outlook for Solarvest on LSS5 plan shortlistMarch 21, 2025 | thestar.com.mySolarvest subsidiary signs PPA for 60MWac solar PV facilityMarch 19, 2025 | thestar.com.mySolarvest In Good Position To Capitalise On Malaysia RE Sector Opportunities - Maybank IBMarch 19, 2025 | bernama.comSolarvest bags EPCC deal valued at RM401milMarch 18, 2025 | thestar.com.mySolarvest unit bags RM401mil EPCC works project under LSS5March 17, 2025 | thestar.com.mySolarvest’s prospects brighten with new projectsFebruary 26, 2025 | thestar.com.mySolarvest net profit jumps 35% in 3Q25February 20, 2025 | thestar.com.mySolarvest's net profit jumps 35% to record RM14.4mil in 3QFY25February 20, 2025 | thestar.com.mySolarvest Holdings Berhad's (KLSE:SLVEST) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?February 3, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in Value3 Quality Stocks Trading Near 52-Week LowsBy Gabriel Osorio-Mazilli | May 30, 2025View 3 Quality Stocks Trading Near 52-Week LowsCAVA's Explosive Growth Makes It a Must-Watch StockBy Gabriel Osorio-Mazilli | May 19, 2025View CAVA's Explosive Growth Makes It a Must-Watch StockWhich U.S. Towns See Economic Change First? [2025 Survey]By MarketBeat Staff | June 9, 2025View Which U.S. Towns See Economic Change First? [2025 Survey]GWI, IWG, GRI, and SVS Company DescriptionsGRI Bio NASDAQ:GRI$1.34 +0.04 (+3.08%) As of 03:31 PM EasternGRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.90624 (IWG.V) CVE:IWGIWG Technologies Inc. is a Canada-based company engaged in aerospace and high-tech businesses. The Company, through its subsidiary, International Water-Guard Industries Inc. (IWG), is engaged in the development, design, manufacture, sale and service of potable water treatment equipment, on-demand water heaters and water systems for international aviation customers. IWG offers an aircraft water system solution in the form of its circulating potable water system. The Company offers its products for business aircraft original equipment manufacturers (OEMs) and business aircraft completion centers across the world. The Company operates its manufacturing, engineering and administrative facility in Burnaby, British Columbia.Solarvest BioEnergy CVE:SVSC$0.02 0.00 (0.00%) As of 09/5/2023Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? 3 Stocks With Rising Dividends Investors Shouldn’t Ignore SoundHound’s AI Growth Story Is Just Getting Started MarketBeat Week in Review – 06/09 - 06/13 2 Reasons Adobe Stock Is Ready to Rally This Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
